VDAC2 loss elicits tumour destruction and inflammation for cancer therapySujing Yuan, Hongbo Chi, Renqiang Sun et al.|Nature|2025Cited by 66
Control of naive T cell reactivity and peripheral tolerance by ascorbate and TET activityXiaolei Hao, Yongqiang Feng, Laura J. Janke et al.|Science Advances|2026Cited by 0